Cysto-Conray II 172 mg/mL

Cysto-Conray II 172 mg/mL is a diagnostic imaging agent used for visualizing the urinary tract. This injection contains iothalamate meglumine and is designed for ureteral administration. It is commonly used in medical procedures to aid in the diagnosis of urinary tract conditions.

Cysto-Conray II 172 mg/mL is primarily used for diagnostic imaging of the urinary tract. It helps in visualizing the kidneys, ureters, and bladder, which can be crucial for identifying blockages, abnormalities, or other conditions. This injection is often administered during procedures to provide clear images for medical evaluation.

The effects of Cysto-Conray II 172 mg/mL are typically observed during diagnostic imaging procedures. It helps to enhance the visibility of the urinary tract structures, allowing healthcare professionals to assess their condition. Common effects may include temporary discomfort or warmth at the injection site.

Cysto-Conray II 172 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper procedures to ensure safety and effectiveness. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Cysto-Conray II 172 mg/mL may interact with certain medications or substances. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the body's response to this diagnostic agent.